Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-25-004706
Filing Date
2025-08-13
Accepted
2025-08-13 19:13:16
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 13166
2 d11778051_ex99-a.htm EX-99 7540
3 d11778051_ex99-b.htm EX-99 837
  Complete submission text file 0000919574-25-004706.txt   23368
Mailing Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656
Business Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656 949-521-7822
RxSight, Inc. (Subject) CIK: 0001111485 (see all company filings)

EIN.: 943268801 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92778 | Film No.: 251213564
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)

Mailing Address 3480 MAIN HIGHWAY SUITE 204 MIAMI FL 33133
Business Address 3480 MAIN HIGHWAY SUITE 204 MIAMI FL 33133 415-378-0636
Divisadero Street Capital Management, LP (Filed by) CIK: 0001901865 (see all company filings)

EIN.: 872846246 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A